Cite

HARVARD Citation

    Lampertico, P. et al. (2013). Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B. Gut. 62 (2), pp. 290-298. [Online]. 
  
Back to record